Is CNBX Pharmaceuticals Inc. (CNBX) a Buy, Sell, or Hold?
OTC : CNBX
CNBX Pharmaceuticals Inc.
$0.0001 USD
$0 (0.0%)
- Volume
- 1.01M
- Average Volume
- 31.57M
- Market Capitalization
- $9.25K
- P/E Ratio
- 0.10
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.00
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.00
Company Overview
OTC
Eyal Barad
Biotechnology
Healthcare
CNBX
1
US
USD
Liquidity Metrics
-0.05
0.00
0.00
0.00
0.00
Sales & Valuation
-$
0.00
-0.05
-0.06
0.00
Profitability
-$0.0035
-$313.98K
0.00%
0.00%
18.01%
-3611.50%
P/E Metrics
0.10
0.00
0.00
Analyst Price Target & Rating
3/5
0 Analysts
%
Financial Health Scores
-3159.69
2/9
-$2.66M
$12795.0
$2.67M
-$431.55K
Key Metrics (TTM)
$119.76K
0.00
-0.28
0.00
18.01%
16.91%
-350.44%
-1666.51%
0 days
Company Executives
| Name | Title |
|---|---|
| Uri Ben-Or | Chief Financial Officer |
| Ilya Reznik | Head of Neuropsychiatry Development |
| Lior Eshdat | Member of Scientific Advisory Board & Vice President of IP |
| Sigalit Ariely-Portnoy | Senior Advisor of Regulation, Validation & Quality and Member of Advisory Board |
| Yaakov Waksman | Head of Cannabidiol Research |
| Tal Mofkadi | Financial Advisor & Member of Advisory Board |
| Eyal Barad | Co-Founder, Chief Executive Officer & Director |
| Gabriel Yariv | President, Chief Operating Officer & Executive Chairman |
| Yasha Borstein | Chief Data Officer |
Poll Results
No votes yet today — be the first to share your view!
About CNBX Pharmaceuticals Inc. (OTC:CNBX) Stock
CNBX Pharmaceuticals Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing cannabinoid-based treatments and therapies for various cancers. Its flagship product candidate, RCC-33, is an oral capsule formulation of cannabinoids specifically engineered for treating colorectal cancer. The company's development pipeline also encompasses several other potential drug candidates, including PLP-33, which targets lateral spreading or sessile colorectal polyps during colonoscopy; BRST-33, aimed at breast cancer; MLN-33, designed for melanoma; and PRST-33, intended for prostate cancer. Furthermore, CNBX is developing Cannabics SR, a lipid-based capsule containing a standardized blend of cannabinoids for managing cancer anorexia-cachexia syndrome, alongside Cannabic ... s CDx, an ex-vivo drug sensitivity diagnostic tool. Incorporated in 2004, the company, based in Bethesda, Maryland, was formerly known as Cannabics Pharmaceuticals Inc. before officially changing its name in March 2022. It operates as a subsidiary of Cannabics Inc.
Frequently Asked Questions
-
What is the current CNBX Pharmaceuticals Inc. (CNBX) stock price?
-
CNBX Pharmaceuticals Inc.(OTC:CNBX) stock price is $0.0001 in the last trading session. During the trading session, CNBX stock reached the peak price of $0.0008 while $0.00005 was the lowest point it dropped to. The percentage change in CNBX stock occurred in the recent session was 0.0% while the dollar amount for the price change in CNBX stock was $0.
-
CNBX's industry and sector of operation?
-
The OTC listed CNBX is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of CNBX?
-
Uri Ben-Or | Chief Financial Officer
Ilya Reznik | Head of Neuropsychiatry Development
Lior Eshdat | Member of Scientific Advisory Board & Vice President of IP
Sigalit Ariely-Portnoy | Senior Advisor of Regulation, Validation & Quality and Member of Advisory Board
Yaakov Waksman | Head of Cannabidiol Research -
How many employees does CNBX have?
-
Number of CNBX employees currently stands at 1. CNBX operates from #3 Bethesda Metro Center, Bethesda, MD 20814, US.
-
Link for CNBX official website?
-
Official Website of CNBX is: https://www.cnbxpharma.com
-
How do I contact CNBX?
-
CNBX could be contacted at phone #877 424 2429 and can also be accessed through its website. CNBX operates from #3 Bethesda Metro Center, Bethesda, MD 20814, US.
-
How many shares of CNBX are traded daily?
-
The average number of CNBX shares traded daily for last 3 months was 31.57M.
-
What is the market cap of CNBX currently?
-
The market value of CNBX currently stands at $9.25K with its latest stock price at $0.0001